Pfizer forms research consortium w/ 4 universities, Entelos to look at diabetes
NEW YORK (Thomson Financial) - Pfizer Inc. Friday said it's formed a research consortium with four universities and private physiological modeling company Entelos to look at diabetes and obesity pathobiology.
The Dow component said the group would 're-examine the regulatory mechanisms of human energy metabolism.' In connection with the consortium, Pfizer said it's funding a three-year, $14 million insulin resistance pathway project to examine at 'insulin signaling in adipose cells to increase understanding of diabetes and obesity.'
The universities involved are University of California, Santa Barbara; Caltech; the Massachusetts Institute of Technology; and University of Massachusetts.
Pfizer shares were up 2% to $20.43 in late trades. Michael Baron mb
COPYRIGHT
Copyright Thomson Financial News Limited 2007. All rights reserved. The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.
